TP53 and cancer: The TP53 gene is one of the most frequently mutated genes in cancers, especially in PDAC, and most of its mutations are missense mutations in the DNA binding domain, resulting in the expression of mutant isoforms of p53, which acquire new oncogenic properties, referred to as gain-of-function (GOF) [9].